Managing Behçet’s disease: An update on current and emerging treatment options

Por van Daele, P LA, Kappen, J H, van Hagen, P M, van Laar, J AM
Publicado em 2009

Adalimumab: a new modality for Behçet's disease?

Por van Laar, J A M, Missotten, T, van Daele, P L A, Jamnitski, A, Baarsma, G S, van Hagen, P M
Publicado em 2007

Diagnostic value of anti-cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjögren's syndrome

Por van Noord, C, Hooijkaas, H, d Dufour-van, van Hagen, P M, van Daele, P L A, van de Merwe, J P
Publicado em 2005

Vertebral deformities as predictors of non-vertebral fractures.

Por Burger, H., van Daele, P. L., Algra, D., Hofman, A., Grobbee, D. E., Schütte, H. E., Birkenhäger, J. C., Pols, H. A.
Publicado em 1994

Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.

Por Pauwels, R, Andries, K, Debyser, Z, Van Daele, P, Schols, D, Stoffels, P, De Vreese, K, Woestenborghs, R, Vandamme, A M, Janssen, C G
Publicado em 1993

Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study.

Por van Daele, P. L., Seibel, M. J., Burger, H., Hofman, A., Grobbee, D. E., van Leeuwen, J. P., Birkenhäger, J. C., Pols, H. A.
Publicado em 1996